{"id":"NCT00863798","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","briefTitle":"Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Evaluate The Efficacy And Safety Of 2 Fixed Doses (10 And 50 mg/Day) Of DVS SR Tablets In Adult Outpatients With Major Depressive Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-04","primaryCompletion":"2010-03","completion":"2010-03","firstPosted":"2009-03-18","resultsPosted":"2011-05-06","lastUpdate":"2011-05-06"},"enrollment":682,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"Desvenlafaxine Succinate Sustained-Release 10mg","otherNames":[]},{"type":"DRUG","name":"Desvenlafaxine Succinate Sustained-Release 50 mg","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Desvenlafaxine succinate sustained release 10 mg","type":"EXPERIMENTAL"},{"label":"Desvenlafaxine succinate sustained release 50 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary purpose of this study is to compare the antidepressant efficacy and safety of two doses of desvenlafaxine succinate sustained release (10 and 50 mg/day) in adults with Major Depressive Disorder. The study will also assess changes in sexual function and general and functional quality of life outcomes.","primaryOutcome":{"measure":"Change From Baseline in HAM-D17 Total Score at Final On-therapy (FOT) Evaluation (Week 8 or ET)","timeFrame":"Baseline and Week 8 (or ET)","effectByArm":[{"arm":"Placebo","deltaMin":-8.42,"sd":0.45},{"arm":"DVS SR 10 mg","deltaMin":-9.28,"sd":0.45},{"arm":"DVS SR 50 mg","deltaMin":-8.92,"sd":0.45}],"pValues":[{"comp":"OG000 vs OG001","p":"0.175"},{"comp":"OG000 vs OG002","p":"0.421"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":24,"countries":["United States"]},"refs":{"pmids":["34183490","29140227","26709542","26644956","25758058","24571916","23517291"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=3151A1-3362&StudyName=Study%20Evaluating%20Desvenlafaxine%20Succinate%20Sustained%20Release%20In%20Adults%20With%20Major%20Depressive%20Disorder"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":223},"commonTop":["Nausea","Headache","Dry mouth","Dizziness","Diarrhoea"]}}